Masimo | MASI - Current Liabilities

Stock Price
175.35
Daily Change
0.25 0.14%
Monthly
25.07%
Yearly
2.71%
Q1 Forecast
169.67

Masimo reported $369.7M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Accuray USD 194.61M 2.03M Sep/2025
Align Technology USD 1.92B 46.45M Dec/2025
AngioDynamics USD 77.97M 10.62M Feb/2025
Artivion USD 85.84M 19.17M Sep/2025
AtriCure USD 81.52M 3.68M Dec/2025
Avanos Medical USD 147.9M 13.3M Sep/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
General Electric Aerospace USD 38.98B 1.78B Dec/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Haemonetics USD 539.87M 8.45M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 9.94B 1.6B Sep/2025
Orthofix International USD 159.85M 11.47M Sep/2025
Owens Minor USD 947.08M 1.52B Dec/2025
ResMed USD 1.25B 7.39M Dec/2025
Steris USD 922.3M 33.4M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 773.03M 56.88M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025